Tyme Technologies (TYME) Announces Board Changes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. JNJ
5. MSFT
6. PLTR
7. QQQ
8. LDOS
9. AXP
10. AON

Go back to Tyme Technologies (TYME) Announces Board Changes

TYME Technologies, Inc. Announces Changes to its Board of Directors

March 25, 2022 8:00 AM EDT

Industry veteran, Christine D. Baker, joins Board of Directors

Douglas A. Michels appointed Chairman of the Board

BEDMINSTER, N.J.--(BUSINESS WIRE)-- TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs), today announced changes to its Board of Directors.

Christine D. Baker Named to Board of Directors

The Company is pleased to announce that Christine D. Baker has been appointed to TYMEs Board of Directors. Ms. Baker brings over 30 years of experience in the biotech/pharmaceutical industry, with expertise in... More